Effectiveness of a Combined Pressure and Silicone Intervention for Hypertrophic Scar Treatment
Effectiveness of a Combined Adequate Pressure and Silicone Intervention in Comparison With Conventional Pressure Therapy for Hypertrophic Scar Treatment: a Randomized Controlled Trial
1 other identifier
interventional
72
0 countries
N/A
Brief Summary
Pressure therapy (PT) and silicone therapy are recommended as first-line non-invasive treatments HS, yet the effectiveness of the combination of these two treatments through an RCT trial has not been established yet. This study aims to examine the effectiveness of the combination of adequate pressure therapy and silicone gel sheeting implemented by Smart Scar Care Pad (SSCP) + Smart Pressure Monitored Suit (SPMS) versus conventional Pressure Garment (PG in the management of severe HS in adult. It is hypothesized that the combination of adequate pressure therapy and silicone gel sheeting will demonstrate its superiority in improving scar parameters than conventional pressure garment therapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2018
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 23, 2018
CompletedFirst Posted
Study publicly available on registry
August 14, 2018
CompletedStudy Start
First participant enrolled
September 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2020
CompletedAugust 14, 2018
August 1, 2018
1.8 years
May 23, 2018
August 9, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from baseline HS thickness at 6 months
HS thickness measured by the Diagnostic Ultrasound System
at baseline, one and six month after treatment
Secondary Outcomes (5)
Change from baseline HS color at 6 months
at baseline, one and six month after treatment
Change from baseline HS pliability at 6 months
at baseline, one and six month after treatment
Change from baseline HS hydration at 6 months
at baseline, one and six month after treatment
Itchiness
at baseline, one and six month after treatment
QoL
at baseline, one and six month after treatment
Study Arms (2)
SSCP + SPMS
EXPERIMENTALPG
ACTIVE COMPARATORInterventions
Eligibility Criteria
You may qualify if:
- The Vancouver Scar Scale (VSS) will be used to screen candidates for the study.10 Isolated scars with a total score of 4 or higher and the score of each item equal to or greater than 1 will be included.
- The scar size should also reach 2\*2 cm2 or above to allow adequate area for assessment tool attachement.
- Consenting adult's age between 19 to 60 years old who is able to provide written consent, cooperative, and good compliance with treatment.
You may not qualify if:
- the HS area have an open wound or infection;
- the HS have been treated with steroid injections or other intervention (such as traditional Chinese medicine or laser therapy) prior to the study;
- the patients have a medical condition that might affect wound healing (e.g., diabetes mellitus or another serious medical problem);
- the patients with comorbidities that might affect their compliance to treatment: such as severe scar contracture at adjacent area that might be scheduled for reconstructive surgery.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Cecilia Li, PhD
The Hong Kong Polytechnic University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- The ultrasound data will be processed and the data will be analysed by analysts who are blinded.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 23, 2018
First Posted
August 14, 2018
Study Start
September 1, 2018
Primary Completion
July 1, 2020
Study Completion
July 1, 2020
Last Updated
August 14, 2018
Record last verified: 2018-08
Data Sharing
- IPD Sharing
- Will not share